The increase of KLRG1+CD8+ T cells in the peripheral blood of non-tumor bearing mice in Figure 1F suggested these cells may be an immune correlate for the complete tumor regression elicited by the triple combination therapy (Figure 2). This evidence concerns the gene CD8A and neoplasm.